You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 12, November 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  EDITORIALS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Chronic Non-A, Non-B Liver Disease

Need for Diagnostic Criteria and Course Definition

Richard E. Sampliner, MD

Arch Intern Med. 1981;141(12):1581-1582.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Acute non-A, non-B (NANB) hepatitis accounts for the vast majority of posttransfusion hepatitis1 and for a large proportion of sporadic hepatitis in adults.2 Recent studies have verified that patients with NANB hepatitis commonly have a prolonged course of aminotransferase level elevation and can progress to notable chronic liver disease.3-7 Now that the serologic techniques for excluding hepatitis A and hepatitis B are clinically available, chronic liver disease resulting from acute NANB hepatitis is being recognized with increasing frequency. How should the clinician deal with chronic NANB liver disease?

First, it is essential to define carefully NANB chronic liver disease. There is a tendency to label all chronic hepatitis lacking serologic markers as NANB. Because the patient with chronic liver disease lacks hepatitis B surface antigen, antinuclear antibody, or lupus erythematosus cells does not necessarily mean he has NANB liver disease. Until a validated specific serologic marker for NANB . . . [Full Text PDF of this Article]


Author Affiliations

Veterans Administration Medical Center 111G Tucson, AZ 85723



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.